Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study
N/A
This study aims to enroll premenopausal patients, with early breast cancer ...
Status
Unknown
Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Long Term Cohort Study of Adding Ovarian Function Suppression to Tamoxifen in Young Women
N/A
This study evaluates the long-term effects of adding 2 years of ovarian fun...
Status
Not Yet Recruiting
Location
Asan Medical Center
Start Date
2026-07-01
Trial ID
NCT07735897
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
PHASE3
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) add...